To include your compound in the COVID-19 Resource Center, submit it here.

FDA statement on BST milk labels

WASHINGTON - Under pressure from interest groups, the FDA last week released its "interim guidance" to states for labeling milk products from cows that have not been treated with recombinant bovine somatotropin. The agency, which was sued Feb. 3 by opponents of the milk increasing growth hormone, reiterated its finding that "no significant difference has been shown between milk drived from rbST-treated and non-rbST-treated cows." The FDA also noted that under such circumstances, it did not have any authority under the Federal Food, Drug, and Cosmetic Act to require special labeling for milk from rbST-treated cows. The agency approved the product last Nov. 5, and marketing began Feb. 4 with the end of

Read the full 1134 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers